The 2024 election results will create significant tailwinds for Republican legislative and regulatory priorities in US Congress, federal agencies, and state houses across the country. This client alert considers the outlook for pharmacy regulation under the second incoming Trump administration and a unified Republican Congress, as well as state-level pharmacy policies that may advance as Republican public policy momentum builds.
Post-Election Outlook: Issues to Watch for Pharmacy Industry Stakeholders
By Steven J. Schnelle and Jae Hyun Lee on December 10, 2024
Posted In Employee Benefits, Health and Welfare Plans
